The University of Rochester RCOE is part of the Department of Neurology’s Movement Disorders Division, which is committed to conducting high quality research, delivering patient and family-centered care, support, and education to those affected by movement disorders, including Parkinson’s disease and related parkinsonian conditions. The movement disorders clinical and research centers are integrated and currently include six movement disorder neurologists, one neuropsychologist, three movement disorders fellows, two nurse practitioners, two RN’s, one social worker and five research coordinators. The movement disorders division faculty and staff collaborate closely with those in our Memory Care Program as well as the Centers for Human Experimental Therapeutics and Telemedicine. The comprehensive approach to patient care in both the movement disorders and memory care programs includes access to formal neuropsychological assessment, cognitive rehabilitation and speech therapy in our Integrated Cognitive Rehabilitation Program in the Department of Physical Medicine and Rehabilitation, psychological and psychiatric care through our Older Adults Service in the Department of Psychiatry, Physical and Occupation Therapy, and case-management and counseling with social workers.
Clinic name: University of Rochester Medical Center, Dept. of Neurology: Movement Disorders Unit
Phone number: 585-341-7500
Website: Movement Disorders Division
Irene Richard, MD
Dr. Richard, Professor of Neurology at UR serves as Director of the Parkinson’s Foundation Center of Excellence and the Movement Disorders Fellowship Training Program. She received her MD from Yale University School of Medicine in 1991, completed a neurology residency at the UR in 1995, and then joined the UR Faculty in 1997 after completing an NIH-funded fellowship training in Movement Disorders and Experimental Therapeutics. She cares for patients with movement disorders such as Parkinson’s disease and related conditions. Her primary research is aimed at better understanding of psychiatric and cognitive symptoms in these disorders to develop effective treatments.